Parabilis Medicines, Inc. share price logo

Parabilis Medicines, Inc.

NASDAQ: PBLS

Mid Cap

$24.44

-2.48

(-9.21%)

as on

Parabilis Medicines, Inc. Stock Performance

as on October 24, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $23.97
    $26.74
    downward going graph

    1.92%

    Downside

    9.41%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Parabilis Medicines, Inc. share price movements today

Previous Close
$26.92
Open
$26.74
Volume
1.8M
Market Cap
$3.0B
Day's Low - High
$23.97 - $26.74

Parabilis Medicines, Inc. Historical Returns

1 Month Return
-21.67 %
3 Month Return
-21.87 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Parabilis Medicines, Inc. Stock Fundamentals & Key Indicators

Check Parabilis Medicines, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.0B

EPS (TTM)

-36.9

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.66

Industry PE ratio

-8.87

PEG Ratio

0.09

EBITDA

-96.1M

Revenue (TTM)

148.0K

Profit Margin

100.00%

Return On Equity TTM

-15.14%

Parabilis Medicines, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Parabilis Medicines, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$3.0BNA-0.66100.00%0.00%
Neutral$79.9B-42.12%-25.08-12.57%0.00%
StrongBuy$43.0BNA27.8687.82%0.00%
StrongBuy$132.8B184.64%30.2586.04%0.00%
Buy$82.9B35.95%19.2284.86%0.46%

Analyst Recommendation on Parabilis Medicines, Inc. Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Parabilis Medicines, Inc.. Average target price of $40.6666666666667

Parabilis Medicines, Inc. Share Price Target

Get share price movements and forecasts by analysts on Parabilis Medicines, Inc..

Current Price

$24.44

Analyzed by

3 Analysts

High

$42

0

Low

$40

Parabilis Medicines, Inc. target price $0, a slight upside of 0% compared to current price of $24.44. According to 3 analysts rating.

Indian Investors' Interest in Parabilis Medicines, Inc. Stock

Search interest for Parabilis Medicines, Inc. Stock has decreased by -34% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-34% versus previous 30 day period

Parabilis Medicines, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2026
Jun 2026
Total Revenue
-
0
Gross Profit
-
0
Operating Income
-47
-50
EBITDA
-44
-51
Interest Expense
0
0
Depreciation
0
0
Income Before Tax
-45
-52
Income Tax Expense
-
-
Net Income
-45
-52
Net Profit Margin
0.00%
100.00%

Parabilis Medicines, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2024
Dec 2025
Total Revenue
-
-
Gross Profit
-
-
Operating Income
-126
-152
EBITDA
-114
-141
Interest Expense
1
1
Depreciation
2
2
Income Before Tax
-117
-145
Income Tax Expense
-
-
Net Income
-117
-145
Net Profit Margin
0.00%
0.00%

Parabilis Medicines, Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2026
Jun 2026
Net Income
-45
-52
Operating Cash Flow
-49
-3
Investing Cash Flow
0
-34
Financing Cash Flow
350
795
Change in Cash
301
758

Parabilis Medicines, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2024
Dec 2025
Net Income
-117
-145
Operating Cash Flow
-103
-123
Investing Cash Flow
30
39
Financing Cash Flow
78
64
Change in Cash
4
-19

Global Institutional Holdings in Parabilis Medicines, Inc.

Check out the Institutions with significant holdings in Parabilis Medicines, Inc..

Funds
Holdings
Peter Kolchinsky
23.73%
Vanguard
2.54%
Andrew J.M. Spokes
1.94%
James E. Flynn
1.54%
iShares
1.17%

Insights on Parabilis Medicines, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, PBLS stock has moved down by -21.7%

About Parabilis Medicines, Inc.

Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
OrganisationParabilis Medicines, Inc.
Headquarters30 Acorn Park Dr, Cambridge, MA, 02140, US
IndustryBiotechnology
CEOMathai Mammen

Key Management of Parabilis Medicines, Inc.

Name

Title

Mr. John McGee Ph.D.

Scientific Co-Founder, Executive Vice President & Head of Platform

Dr. Jonathan Hurov Ph.D.

Executive Vice President of Discovery Biology

Dr. Huei-in Ho Ph.D.

Chief Business & Strategy Officer

Dr. Mathai Mammen M.D., Ph.D.

CEO, President, Treasurer & Chairman

Ms. Teresa L. Jurgensen J.D.

Executive VP, Secretary & General Counsel

Mr. Thomas Rodolpho Kotarakos

Chief Financial Officer

Dr. Rohin Mhatre Ph.D.

Chief Technical Operations Officer

Ms. Kristen Stants

Chief People Officer

Ms. Marie Nguyen M.D.

Senior VP & Head of Clinical Development

Dr. Markus Haeberlein MSc, Ph.D.

Executive Vice President of Discovery Science

FAQs

What is Parabilis Medicines, Inc. share price today?

Parabilis Medicines, Inc. share price today is $24.44 as on at the close of the market. Parabilis Medicines, Inc. share today touched a day high of $26.74 and a low of $23.97.

What is the 52 week high and 52 week low for Parabilis Medicines, Inc. share?

Parabilis Medicines, Inc. share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Parabilis Medicines, Inc. stock price today i.e. is closed at $24.44,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Parabilis Medicines, Inc.'s market capitalisation today?

Parabilis Medicines, Inc. market capitalisation is $0.00T as on .

How to invest in Parabilis Medicines, Inc. Stock (PBLS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Parabilis Medicines, Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Parabilis Medicines, Inc. Stock (PBLS) from India?

Indian investors can start investing in Parabilis Medicines, Inc. (PBLS) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Parabilis Medicines, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Parabilis Medicines, Inc. share’s latest price of $24.44 as on October 24, 2026 at 8:45 am IST, you will get 0.4092 shares of Parabilis Medicines, Inc.. Learn more about fractional shares .